ENDRA Life Sciences Inc
0.0 %
0.0 %
Yet to be announced
Company Overview
ENDRA Life Sciences Inc is a medical technology company focused on developing and commercializing innovative medical imaging solutions. Their primary product is TAEUS (Thermo-Acoustic Enhanced UltraSound), which is designed to enable clinicians to visualize human tissue composition, function, and temperature in ways previously possible only with CT & MRI - at a fraction of the cost and at the point of care.
Revenue Sources
Based on the financial data provided, ENDRA Life Sciences Inc currently generates no revenue as they are in the pre-revenue, research and development phase. The company is focused on developing their TAEUS technology and has not yet commercialized their products. Since the company is pre-revenue, we skip this check as per our methodology.
Reliance on Interest
| Reporting Date | Total Revenue | Total Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
The company is pre-revenue and still in development phase. While there is interest expense reported in one quarter (-3,071,252 USD in Q3 2024), we do not perform the interest expense ratio calculation since the company has not reached its mature operational stage. As per our methodology, we skip this check for pre-revenue companies still in R&D mode.
Operational Ethics
After reviewing available SEC filings and company information, there is no evidence of any material ongoing associations with entities involved in human rights violations such as the state of Israel or the Chinese Communist Party.
Login to join the discussion